Aevi Genomic Medicine, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.38%219.450.0%$1922.39m
BIIBBiogen, Inc. -1.72%374.351.7%$1312.00m
SNSSSunesis Pharmaceuticals, Inc. -7.33%11.880.7%$830.46m
NVAXNovavax, Inc. 6.73%193.1779.8%$801.16m
AMGNAmgen, Inc. -0.07%240.081.3%$663.02m
BNTXBioNTech SE 3.57%234.160.0%$572.68m
VRTXVertex Pharmaceuticals, Inc. 0.49%188.621.9%$536.71m
GILDGilead Sciences, Inc. -0.39%67.091.0%$496.08m
REGNRegeneron Pharmaceuticals, Inc. 0.02%534.402.7%$388.50m
ILMNIllumina, Inc. 0.58%463.713.5%$351.39m
ALXNAlexion Pharmaceuticals, Inc. -0.57%179.622.0%$337.96m
OCGNOcugen, Inc. -5.56%6.990.0%$323.68m
TXG10X Genomics, Inc. 0.10%198.070.0%$177.52m
EXASEXACT Sciences Corp. 0.49%128.2918.1%$177.28m
TECHBio-Techne Corp. 0.17%440.974.5%$164.12m

Company Profile

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.